MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $755,404 | -33.4% | 47,095 | -3.7% | 0.00% | -40.0% |
| Q2 2023 | $1,133,827 | +1.9% | 48,914 | +2.1% | 0.01% | 0.0% |
| Q1 2023 | $1,112,856 | +136112.5% | 47,906 | -14.9% | 0.01% | +25.0% |
| Q4 2022 | $817 | -25.3% | 56,325 | -1.6% | 0.00% | -20.0% |
| Q3 2022 | $1,093 | -99.9% | 57,262 | +5.9% | 0.01% | 0.0% |
| Q2 2022 | $982,000 | -24.6% | 54,062 | +4.7% | 0.01% | 0.0% |
| Q1 2022 | $1,302,000 | +7.8% | 51,659 | +18.0% | 0.01% | +25.0% |
| Q4 2021 | $1,208,000 | -13.8% | 43,771 | +1.0% | 0.00% | -20.0% |
| Q3 2021 | $1,401,000 | +3.3% | 43,354 | -2.2% | 0.01% | 0.0% |
| Q2 2021 | $1,356,000 | -0.4% | 44,335 | -0.9% | 0.01% | -16.7% |
| Q1 2021 | $1,362,000 | +52.3% | 44,735 | -1.0% | 0.01% | +50.0% |
| Q4 2020 | $894,000 | +55.7% | 45,197 | +2.7% | 0.00% | +33.3% |
| Q3 2020 | $574,000 | +15.0% | 43,991 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $499,000 | -26.2% | 43,991 | -6.9% | 0.00% | -50.0% |
| Q1 2020 | $676,000 | -47.9% | 47,258 | -0.9% | 0.00% | -33.3% |
| Q4 2019 | $1,298,000 | -17.0% | 47,690 | -12.7% | 0.01% | -14.3% |
| Q3 2019 | $1,564,000 | +10.8% | 54,628 | +7.4% | 0.01% | 0.0% |
| Q2 2019 | $1,412,000 | -14.5% | 50,845 | +2.3% | 0.01% | -12.5% |
| Q1 2019 | $1,651,000 | +13.2% | 49,705 | -1.0% | 0.01% | 0.0% |
| Q4 2018 | $1,459,000 | -30.7% | 50,186 | +9.7% | 0.01% | -20.0% |
| Q3 2018 | $2,105,000 | +18.5% | 45,763 | -3.7% | 0.01% | +11.1% |
| Q2 2018 | $1,776,000 | +22.2% | 47,523 | -3.4% | 0.01% | +28.6% |
| Q1 2018 | $1,453,000 | -22.2% | 49,184 | -9.5% | 0.01% | -12.5% |
| Q4 2017 | $1,867,000 | -14.4% | 54,349 | -9.8% | 0.01% | -27.3% |
| Q3 2017 | $2,180,000 | +31.6% | 60,266 | -5.9% | 0.01% | +37.5% |
| Q2 2017 | $1,656,000 | +32.5% | 64,075 | -1.6% | 0.01% | +33.3% |
| Q1 2017 | $1,250,000 | -79.3% | 65,125 | -58.3% | 0.01% | -82.4% |
| Q3 2014 | $6,028,000 | -0.9% | 156,300 | 0.0% | 0.03% | 0.0% |
| Q2 2014 | $6,083,000 | +99.9% | 156,300 | +75.6% | 0.03% | +88.9% |
| Q1 2014 | $3,043,000 | – | 89,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |